Hong Kong Stock Market Update | Innovent Bio and Takeda Pharmaceutical Reach Global Strategic Cooperation and Issue Shares Under General Authorization

Stock News
10/22

【Major Developments】Innovent Bio (01801) has established a global strategic cooperation with Takeda Pharmaceutical Co Ltd and will issue shares under general authorization. China Unicom (00762) plans to spin off Zhixun Technology for listing on the Shenzhen Stock Exchange's ChiNext Market. Laopu Gold (06181) intends to issue approximately 3.71 million new H shares at a discount of about 4.50%, raising around HKD 2.707 billion. Sine Sage International (00732) aims to acquire approximately 11.43% equity in Sine Sage Ren Shou through a public tender. Xuan Bamboo Biotech-B (02575) will present clinical phase III data on Pirpocitib for the first-line treatment of HR+/HER2- advanced breast cancer at ESMO 2025. Kingfa Sci & Tech-B (02595) has completed the first patient dosing in its Ib/II clinical trial for the KRAS G12D inhibitor GFH375 combined with Cetuximab or chemotherapy for the treatment of advanced solid tumors. Wihardta Holdings (00622) plans to sell Shenyang H shares for HKD 503 million. Huajian Medical (01931) intends to change its English name to "ETHK Labs Inc." Nuo Hui Health's (06606) listing status will be canceled starting October 27. Xunkun Real Estate (06900) and Jianzhong Construction (00589) will also have their listing status canceled from October 27. 【Repurchases/Changes in Holdings】Midea Group (00300) repurchased 1.3584 million A shares for HKD 99.996 million on October 22. AAC Technologies (02018) spent approximately HKD 11.9098 million to buy back 300,000 shares on October 22. Lianyi Ruan Technology-W (09959) repurchased 2.43 million shares at a cost of HKD 7.47075 million on October 22. Mengniu Dairy (02319) repurchased 500,000 shares for HKD 7.1714 million on October 22. Fang Feng Lithium (01772) Vice President Fu Lihua plans to reduce his stake in the company by up to 40,000 shares. 【Operational Performance】China Unicom (00762) reported a three-quarter profit of RMB 20 billion, a year-on-year increase of 5.1%. China Railway (00390) signed new contracts totaling RMB 1,584.92 billion in the first nine months, a year-on-year increase of 3.7%. China Communications Construction (01800) posted new contracts of RMB 1,339.97 billion in the first three quarters, up 4.65% year-on-year. CATHAY PAC AIR (00293) recorded a 21% year-on-year increase in passenger numbers in September. Tao Bo (06110) published its interim results, with profits attributable to equity holders totaling approximately RMB 789 million, a 9.69% decrease year-on-year. Shanghai Petrochemical Co (00338) reported a net loss of RMB 432 million for the first three quarters.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10